All Type of News
Keunwha declared 10 billion won of Somalgen sales in 2006.
Keunwha took a declaring ceremony for the sales of Somalgen to achieve 10 billion won in 2006 during the 20th anniversary of Somgalen market launching.
In the meeting the company invited Prof. Lee Soo-ho, Seoul Asa...
Priority of NHI subsidy program for low income people.
The government announced that the NHI subsidy program would be given with priority to the low income people after reflecting it to the revised NHI Financial Stabilizing Act.
The MOHW made it clear that the NHI fina...
2 hours earlier for evening service charges from February.
Taking effect from coming February, the special evening service charges seems to be advanced with 2 hours, namely, applying it from 6:00 p.m instead of the current 8:00 p.m. on weekdays and 1:00 p.m. instead of 3:00 p...
Number of drug adverse reaction reports on the rise.
Given the recent atmosphere of which the drug safety problems seriously alerted to the public concerns, the drug adverse reaction report doubled in its number, showing a sharp rising trend from 363 cases in 2001 to 14...
Samjin in strategic alliance with ImQuest over anti-viral drug development.
Samjin announced to make a strategic alliance with ImQuest, an American company, for the clinical research of new anti-viral drugs developed by Samjin according to Fox 5 news, a foreign correspondence.
The news sai...
Government price review to save 58 BW by slashing l469 drugs by 9%
The NHI prices of 1,469 drugs produced by 186 companies seem to cut off by 9%, saving about 58 billion won a year.
The government completed the 2005 drug price review works and released them for the relevant drug c...
59 new drugs registered from 2003 to 2005.
It is reported that the total 59 new drugs had been registered in Korea during the past 3 years, and that the foreign multinational drug corporations imported such new drugs in a finished package form by 100% while th...
Amantadine drugs to prohibit for A flu treatment.
The medication of Amandatine or Remantadine preparations for the treatment or prevention of A type flu is not reimbursable by the NHI.
Recently, the KFDA recommended to physicians and pharmacists not to use the am...
Dong-A distributing a new type of Quinolone antibiotics.
Dong-A made an agreement with Toyama Chemical of Japan on Jan. 20 for the exclusive distribution of Garenoxacin, a new type of quinolone antibiotics, in Korea.
Garenoxacin is a new and unique compound, developed by...
Jinyang to patent an anti-cancer therapy in America.
Jinyang pharmaceutical company, a Kosdaq listed company of Korea, announced that the company took a patent registration of an anti-leukemia drug in the United States under the number of Pat. No. 6989143.
The comp...
